Medical Equipment

Global Neuroscience Antibodies & Assays Market Valuation and Growth Prospects: $8.62 Billion by 2029

December 4, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the neuroscience antibodies & assays market from 2025–2034 with trusted insights from The Business Research Company

What Are The Future Growth Projections For The Neuroscience Antibodies & Assays Market Size?

The neuroscience antibodies & assays market has experienced rapid expansion in recent years. It is forecast to grow from $4.52 billion in 2024 to $5.03 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 11.4%. Historically, this expansion can be attributed to increased research funding, advancements in drug discovery and development, the rising incidence of neurodegenerative diseases, various government initiatives, and the development of personalized medicine.

The neuroscience antibodies & assays market is set to experience substantial expansion in the coming years. It is forecast to attain a size of $8.62 billion by 2029, growing at a compound annual growth rate (CAGR) of 14.4%. This anticipated growth during the forecast period is primarily driven by collaborations, the integration of telemedicine in neurology, advancements in education and training, the rise of biomarker-driven therapies, and an increased emphasis on neuroimmunology. Significant trends expected in this period encompass microrna and non-coding rna assays, digital pathology, advanced imaging-compatible assays, single-cell analysis, and the utilization of 3D organoid models.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7548&type=smp

What Core Market Drivers Are Expanding The Neuroscience Antibodies & Assays Industry?

The increasing occurrence of neurological illnesses worldwide is expected to drive the growth of the neuroscience antibodies & assays market. Neurological illnesses encompass disorders that affect the nervous system, exemplified by conditions such as epilepsy, Alzheimer’s disease, and dementia. The rising prevalence of these illnesses necessitates increased research and development initiatives focused on their treatment. Antibodies and assays play a crucial role in these R&D activities, enabling the study of the nervous system’s development, systems, structure, function, and various disorders and degenerations. Hence, the neuroscience antibodies & assays market expands as the incidence of neurological illnesses grows. For instance, in May 2024, the Centers for Disease Control and Prevention reported that around 2.9 million U.S. adults aged 18 and older experienced active epilepsy during 2021 and 2022. Additionally, the Alzheimer’s Association noted that 6.5 million people in the US were affected by Alzheimer’s disease as per 2022 data. This global surge in neurological illness incidence is consequently propelling the neuroscience antibodies and assays market forward.

What Segment Insights Are Highlighted In The Neuroscience Antibodies & Assays Market Report?

The neuroscience antibodies & assaysmarket covered in this report is segmented –

1) By Product: Consumables, Instruments

2) By Technology: Molecular Diagnostics, Clinical Chemistry, Immunoassays Or Immunochemistry, Others Technologies

3) By Application: In Vitro Diagnostics, Research, Drug Discovery

4) By End User: Hospitals And Diagnostics Centers, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies

Subsegments:

1) By Consumables: Antibodies, Assay Kits, Assay Kits

2) By Instruments: Spectrophotometers, Microplate Readers, Flow Cytometers, Western Blotting Systems, Imaging Systems, Automated Workstations

Which Notable Trends Are Transforming The Neuroscience Antibodies & Assays Market Outlook?

Technological progress represents a pivotal trend gaining significant momentum within the neuroscience antibodies and assays market. Prominent companies active in the market are bringing forth novel technologies, such as NeuroNexus Summa Framework technology, to maintain their competitive standing. For example, in February 2022, NeuroNexus Technologies, a US-based provider of innovative neural interface products and technologies, unveiled the NeuroNexus Summa Framework. This offering was engineered to allow both seasoned electrophysiologists and life science researchers to readily integrate electrical signal read-outs from biological cells and tissues into their research procedures.

Which Firms Are Driving Innovation Within The Neuroscience Antibodies & Assays Market?

Major companies operating in the neuroscience antibodies & assays market include Abcam plc, BioLegend Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Merck KGaA, Rockland Immunochemicals Inc., GenScript Biotech Corporation, Santa Cruz Biotechnology Inc., Wak-Chemie Medical GmbH, Epitope Diagnostics Inc., Agilent Technologies, Bio-Techne Corporation, Creative Diagnostics, Enzo Life Sciences Inc., Jackson ImmunoResearch Laboratories Inc., Novus Biologicals LLC, OriGene Technologies Inc., Proteintech Group Inc., R&D Systems Inc., RayBiotech Inc., StressMarq Biosciences Inc., Synaptic Systems GmbH, Tocris Bioscience, Alomone Labs Ltd., AnaSpec Inc., Antibodies.com, Antibody Solutions, Arbor Assays, Uscn Life Science Inc., Zymo Research Corp., AAT Bioquest Inc., Abbexa Ltd., ACROBiosystems Inc., Active Motif Inc., AdipoGen Life Sciences, Advanced Targeting Systems Inc., AgriSera AB

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/neuroscience-antibodies-and-assays-global-market-report

What Regional Trends Are Shaping Growth In The Neuroscience Antibodies & Assays Market?

North America was the largest region in the neuroscience antibodies & assays market in 2024. The regions covered in the neuroscience antibodies & assays market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=7548&type=smp

Browse Through More Reports Similar to the Global Neuroscience Antibodies & Assays Market 2025, By The Business Research Company

Neurology Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurology-devices-global-market-report

Neurodegenerative Disorder Therapeutic Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurodegenerative-disorder-therapeutic-global-market-report

Neurophysiology Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurophysiology-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795